iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA: IHE · Real-Time Price · USD
94.75
-0.32 (-0.34%)
Jun 12, 2026, 4:00 PM EDT - Market closed
IHE Holdings Information
IHE is an equity ETF with a total of 59 individual holdings. The top holdings are Eli Lilly and Company stock at 24.56%, Johnson & Johnson at 20.74%, Royalty Pharma at 5.01%, Viatris at 4.85%, and Merck & Co. at 4.40%.
Total Holdings
59
Top 10 Percentage
77.28%
Asset Class
Equity
ETF Category
Health
Assets
921.54M
PE Ratio
22.07
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 24.56% |
| 2 | JNJ | Johnson & Johnson | 20.74% |
| 3 | RPRX | Royalty Pharma plc | 5.01% |
| 4 | VTRS | Viatris Inc. | 4.85% |
| 5 | MRK | Merck & Co., Inc. | 4.40% |
| 6 | PFE | Pfizer Inc. | 4.05% |
| 7 | BMY | Bristol-Myers Squibb Company | 4.01% |
| 8 | JAZZ | Jazz Pharmaceuticals plc | 3.70% |
| 9 | ELAN | Elanco Animal Health Incorporated | 3.08% |
| 10 | ZTS | Zoetis Inc. | 2.87% |
| 11 | AXSM | Axsome Therapeutics, Inc. | 2.77% |
| 12 | CORT | Corcept Therapeutics Incorporated | 2.01% |
| 13 | LGND | Ligand Pharmaceuticals Incorporated | 1.29% |
| 14 | LQDA | Liquidia Corporation | 1.27% |
| 15 | INDV | Indivior PLC | 1.23% |
| 16 | OGN | Organon & Co. | 0.90% |
| 17 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.89% |
| 18 | AMRX | Amneal Pharmaceuticals, Inc. | 0.72% |
| 19 | SUPN | Supernus Pharmaceuticals, Inc. | 0.67% |
| 20 | EWTX | Edgewise Therapeutics, Inc. | 0.65% |
| 21 | TARS | Tarsus Pharmaceuticals, Inc. | 0.63% |
| 22 | DFTX | Definium Therapeutics, Inc. | 0.61% |
| 23 | PBH | Prestige Consumer Healthcare Inc. | 0.58% |
| 24 | NKTR | Nektar Therapeutics | 0.48% |
| 25 | ELVN | Enliven Therapeutics, Inc. | 0.46% |
As of Jun 11, 2026